Refractory immune thrombocytopenia

Drug	Drug Name	Drug Description
DB01406	Danazol	A synthetic steroid and pituitary gonadotropin inhibitor used in the treatment of endometriosis and symptomatic treatment of severe pain and tenderness associated with benign fibrocystic breasts.
DB05332	Romiplostim	A fusion protein thrombopoietin (TPO) peptide analog that increases platelet counts by binding to and activating the human TPO receptor. Used to treat thrombocytopenia associated with chronic immune thrombocytopenia (ITP).

Drug	Drug Name	Target	Type
DB01406	Danazol	Estrogen receptor alpha	target
DB01406	Danazol	Gonadotropin-releasing hormone receptor	target
DB01406	Danazol	Putative gonadotropin-releasing hormone II receptor	target
DB01406	Danazol	Sex hormone-binding globulin	carrier
DB01406	Danazol	C-C motif chemokine 2	target
DB01406	Danazol	Cytochrome P450 19A1	enzyme
DB01406	Danazol	Androgen receptor	target
DB01406	Danazol	Progesterone receptor	target
DB01406	Danazol	Cytochrome P450 3A4	enzyme
DB05332	Romiplostim	Thrombopoietin receptor	target

Drug	Drug Name	Phase	Status	Count